Addressing Alzheimer’s Disease Diagnostics and Barriers to Care Roundtable: A Policy Approach

Name: Addressing Alzheimer’s Disease Diagnostics and Barriers to Care Roundtable: A Policy Approach
Start: 2024-12-09T09:30:00-05:00
End: 2024-12-09T15:30:00-05:00

December 9, 2024 @ 9:30 am - 3:30 pm EST

The Society for Women’s Health Research is convening an interdisciplinary Alzheimer’s disease diagnostics roundtable of public health researchers and professionals, policymakers, and health care providers for a closed, roundtable meeting. The roundtable will discuss advancements and breakthroughs in diagnosis and staging; federal policy; caregiving; and improving access to more timely and earlier diagnosis, among other topic areas.

Details

Date:: December 9, 2024
Time:: 9:30 am - 3:30 pm EST
Event Categories:: Policymaker Event, Roundtable, SWHR Event

Organizer

: SWHR

Objectives

The objectives of the roundtable will be shared soon.

Roundtable Participants

Maheen Adamson, PhD, Clinical Professor, Neurology

Sheena Aurora, MD, Vice President of Neurology, C2N Diagnostics

Joel Braunstein, MD, MBA, Co-Founder and CEO of C2N Diagnostics

Melanie Chadwick, CRNP, Gerontological Research Nurse Practitioner (GNP), Georgetown University

Wen Dombrowski, MD, MBA, Adjunct Professor, USC Leonard Davis School of Gerontology and Chief Convergence Officer, CATALAIZE

Rebecca Edelymayer, MD, Vice President of Scientific Engagement, Alzheimer’s Association

Hampus Hillerstrom, MS Economics, MS Health Science & Technology, MBA, President and CEO, LuMind IDSC

Ian Kremer, JD, Executive Director, LEAD Coalition

Lisa McGuire, PhD, FGSA, Vice President of Strategic Alliances and Practice Innovation, Gerontological Society of America

Jennifer Pollack, JD, Director of Access Policy, Alzheimer’s Association

Jennifer Snow, MPH, Founder of Apteka

Deanna R. Willis, MD, Professor of Family Medicine and Vice Chair of Research, IU School of Medicine

Sponsor

Support for this program has been provided by Eli Lilly & Co and Roche. SWHR maintains independence and editorial control over program development, content, and work products.